Asia-Pacific Psoriasis Drugs Market by Drug Type (Pharmaceuticals and Biopharmaceuticals), by Route of Administration (Topical and Systemic), and by Target (Tumour Necrosis Factor, Phosphodiesterase Type 4, Interleukin, and Others) - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Asia-Pacific Psoriasis Drugs Market by Drug Type (Pharmaceuticals and Biopharmaceuticals), by Route of Administration (Topical and Systemic), and by Target (Tumour Necrosis Factor, Phosphodiesterase Type 4, Interleukin, and Others) - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 1721 | Pages: 140 | December 2016 | Region: Asia Pacific


Asia-Pacific Psoriasis Drugs Market is expected to reach USD 1.6 billion by 2021 from USD 1.1 billion in 2016, growing at a CAGR of 8.24% during the forecast period 2016-2021. Psoriasis is noncommunicable inflammatory skin condition that alter the life cycle of skin cells by speeding up the growth of cells on the surface of the skin. Rapid development of cells produces thick, silver scales, and makes the skin red, dry, flaky, and itchy. Currently, no permanent cure is available for the disease, however preventative measures can be adopted to slow down the growth of skin cells on the surface of the skin. Psoriasis can be treated either with pharmaceuticals or biopharmaceuticals therapies through topical and systemic process. These medications administered either by applying on the skin, or consumed orally, or through injections specifically block parts of immune system process by specifically targeting Tumour Necrosis Factor (TNF), Phosphodiesterase Type 4 (PDE4), Interleukin, among others.

The growth of Psoriasis Drugs market is majorly driven by factors such as rising healthcare expenditure, introduction of novel and more efficient drug, and expected entry of late-stage products. The key restraints of the market are high cost involved in drug development, patent expiry of brand name drugs, and low efficacy of the product. Additionally, Psoriasis is not very prevalent in Asia-Pacific reason further restricting the growth for the product.

Asia-Pacific Psoriasis Drugs Market is segmented on the basis of Drug Type, Route of Administration, and Target. Based on Drug Type, the market is classified into Pharmaceuticals and Biopharmaceuticals. On the basis of Route of Administration, the market is classified into Topical and Systemic (Oral, Intravenous, and Others). On the basis of Target, the market is classified into Tumour Necrosis Factor, Phosphodiesterase Type 4, Interleukin, and Others

The Asia-Pacific market is geographically segmented into China, India, Japan, South Korea and Australia.

The major companies dominating the Asia-Pacific Psoriasis Drugs Market are Johnson & Johnson (USA), Novartis International AG (Switzerland), Pfizer Inc (USA), Merck and Co. Inc (USA), Celgene Corporation (USA), Janssen Biotech Inc (USA), Stiefel Laboratories Inc (USA), Takeda Pharmaceutical Company Limited (Japan), Amgen (USA), and AbbVie (USA).

1.Introduction                                                  

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 Epidemology                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 Drug Type                                   

                                5.1.1 Introduction                           

                                5.1.2 Pharmaceuticals                   

                                5.1.3 Biopharmaceuticals                             

                                5.1.4  Y-o-Y Growth Analysis, By Drug Type                          

                                5.1.5  Market Attractiveness Analysis, By Drug Type                        

                                5.1.6  Market Share Analysis, By Drug Type                         

                5.2 Route of Administration                                       

                                5.2.1 Introduction                           

                                5.2.2 Topical                      

                                5.2.3 Systemic                  

                                                                5.2.3.1 Oral

                                                                5.2.3.2 Intravenous

                                                                5.2.3.3 Other

                                5.2.4  Y-o-Y Growth Analysis, By Route of Administration                              

                                5.2.5  Market Attractiveness Analysis, By Route of Administration                            

                                5.2.6  Market Share Analysis, By Route of Administration                             

                5.3 Target                                           

                                5.3.1 Introduction                           

                                5.3.2 Tumour Necrosis Factor (TNF)                        

                                5.3.3 Phosphodiesterase Type 4 (PDE4)                

                                5.3.4 Interleukin                              

                                5.3.5 Others                      

                                5.3.6  Y-o-Y Growth Analysis, By Target                 

                                5.3.7  Market Attractiveness Analysis, By Target                               

                                5.3.8  Market Share Analysis, By Target                 

6. Geographical Analysis                                                              

                6.1 Introduction                                               

                                6.1.1 Regional Trends                    

                                6.1.2 Impact Analysis                     

                                6.1.3 Y-o-Y Growth Analysis                        

                                                6.1.3.1 By Geographical Area     

                                                6.1.3.2 By Product           

                                                6.1.3.3 By Type 

                                                6.1.3.4 By Application    

                                                6.1.3.5 By Indication       

                                6.1.4  Market Attractiveness Analysis                     

                                                6.1.4.1 By Geographical Area     

                                                6.1.4.2 By Product           

                                                6.1.4.3 By Type 

                                                6.1.4.4 By Application    

                                                6.1.4.5 By Indication       

                                6.1.5  Market Share Analysis                      

                                                6.1.5.1 By Geographical Area     

                                                6.1.5.2 By Product           

                                                6.1.5.3 By Type 

                                                6.1.5.4 By Application    

                                                6.1.5.5 By Indication       

                6.2 China                                             

                6.3 India                                              

                6.4 Japan                                            

                6.5 South Korea                                               

                6.6 Australia                                      

7.Strategic Analysis                                                        

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8.Market Leaders' Analysis                                                         

                8.1 Johnson & Johnson                                 

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Financial analysis                  

                                8.1.4 Recent Developments                       

                                8.1.5 SWOT analysis                       

                                8.1.6 Analyst View                          

                8.2 Novartis International AG                                    

                8.3 Pfizer Inc                                     

                8.4 Merck and Co. Inc                                    

                8.5 Celgene Corporation                                              

                8.6 Janssen Biotech Inc                                                 

                8.7 Stiefel Laboratories Inc                                          

                8.8 Takeda Pharmaceutical Company Limited                                     

                8.9 Amgen                                         

                8.10 AbbVie                                       

9.Competitive Landscape                                                            

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10.Market Outlook and Investment Opportunities                                                          

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Asia-Pacific Psoriasis Drugs Market By Systemic, From 2016-2021 ( USD Billion )
  2. Asia-Pacific Oral Systemic Route Market By Region, From 2016-2021 ( USD Billion )
  3. Asia-Pacific Intravenous Systemic Route Market By Region, From 2016-2021 ( USD Billion )
  4. Asia-Pacific Others Systemic Route Market By Region, From 2016-2021 ( USD Billion )
  5. Japan Psoriasis Drugs Market By Systemic, From 2016-2021 ( USD Billion )
  6. China Psoriasis Drugs Market By Systemic, From 2016-2021 ( USD Billion )
  7. India Psoriasis Drugs Market By Systemic, From 2016-2021 ( USD Billion )
  8. Australia Psoriasis Drugs Market By Systemic, From 2016-2021 ( USD Billion )
North America High Potency Active Pharmaceutical Ingredients Market By Type (Innovative HPAPI’s And Generic HPAPI’s), By Synthesis (Biotech HPAPI’s And Synthetic HPAPI’s), By Therapeutic Application (Oncolog...
Middle East And Africa High Potency Active Pharmaceutical Ingredients Market By Type (Innovative HPAPI’s And Generic HPAPI’s), By Synthesis (Biotech HPAPI’s And Synthetic HPAPI’s), By Therapeutic Application...
Latin America High Potency Active Pharmaceutical Ingredients Market By Type (Innovative HPAPI’s And Generic HPAPI’s), By Synthesis (Biotech HPAPI’s And Synthetic HPAPI’s), By Therapeutic Application (Oncolog...
Europe High Potency Active Pharmaceutical Ingredients Market By Type (Innovative HPAPI’s And Generic HPAPI’s), By Synthesis (Biotech HPAPI’s And Synthetic HPAPI’s), By Therapeutic Application (Oncology, Glau...
Asia Pacific High Potency Active Pharmaceutical Ingredients Market By Type (Innovative HPAPI’s And Generic HPAPI’s), By Synthesis (Biotech HPAPI’s And Synthetic HPAPI’s), By Therapeutic Application (Oncology...
High Potency Active Pharmaceutical Ingredients Market By Type (Innovative HPAPI’s And Generic HPAPI’s), By Synthesis (Biotech HPAPI’s And Synthetic HPAPI’s), By Therapeutic Application (Oncology, Glaucoma, H...
North America Cannabis Testing Market By Product & Software (Analytical Instruments, Consumables And Software), By Testing Procedures (Terpene Profiling, Potency Testing, Residual Solvent Screening, Pesticide Screen...
Middle East And Africa Cannabis Testing Market By Product & Software (Analytical Instruments, Consumables And Software), By Testing Procedures (Terpene Profiling, Potency Testing, Residual Solvent Screening, Pestici...
Latin America Cannabis Testing Market By Product & Software (Analytical Instruments, Consumables And Software), By Testing Procedures (Terpene Profiling, Potency Testing, Residual Solvent Screening, Pesticide Screen...
Europe Cannabis Testing Market By Product & Software (Analytical Instruments, Consumables And Software), By Testing Procedures (Terpene Profiling, Potency Testing, Residual Solvent Screening, Pesticide Screening, Ge...
Asia Pacific Cannabis Testing Market By Product & Software (Analytical Instruments, Consumables And Software), By Testing Procedures (Terpene Profiling, Potency Testing, Residual Solvent Screening, Pesticide Screeni...
Global Cannabis Testing Market By Product & Software (Analytical Instruments, Consumables And Software), By Testing Procedures (Terpene Profiling, Potency Testing, Residual Solvent Screening, Pesticide Screening, Ge...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
502, Kakatiya's Empire,
Jubilee Gardens, Hyderabad,
Telangana, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.